{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Ketofol for Procedural Sedation and Analgesia in the Pediatric Population ((Non-Physician Credit))

Activity Steps


The certificate for this activity is for NON-PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the pharmacology, dosing, indications, and risks of using propofol or ketamine as agents for procedural sedation and analgesia (PSA).
  2. Describe the benefits and risks of using ketamine and propofol in conjunction, commonly known as ketofol, for PSA.
  3. Summarize the literature discussing the adverse event profile of using ketofol for PSA compared with alternative sedation regimens.
Price: FREE


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Test Code: PECN0122
Published: January 2022
Expires: 12/31/2023
Required Passing Score: 4/5 (80%)
Authors: Ammarah U. Iqbal, MD, Megan E. Shuster, PharmD, and Carl R. Baum, MD
Topics: Analgesia , Ketofol , Sedation